Research Article | Open Access
Niv Bachnoff, Moshe Cohen-Kutner, Daphne Atlas, "The Involvement of Ser1898 of the Human L-Type Calcium Channel in Evoked Secretion", International Journal of Endocrinology, vol. 2011, Article ID 746482, 13 pages, 2011. https://doi.org/10.1155/2011/746482
The Involvement of Ser1898 of the Human L-Type Calcium Channel in Evoked Secretion
A PKA consensus phosphorylation site S1928 at the α11.2 subunit of the rabbit cardiac L-type channel, CaV1.2, is involved in the regulation of CaV1.2 kinetics and affects catecholamine secretion. This mutation does not alter basal CaV1.2 current properties or regulation of CaV1.2 current by PKA and the beta-adrenergic receptor, but abolishes CaV1.2 phosphorylation by PKA. Here, we test the contribution of the corresponding PKA phosphorylation site of the human α11.2 subunit S1898, to the regulation of catecholamine secretion in bovine chromaffin cells. Chromaffin cells were infected with a Semliki-Forest viral vector containing either the human wt or a mutated S1898A α11.2 subunit. Both subunits harbor a T1036Y mutation conferring nifedipine insensitivity. Secretion evoked by depolarization in the presence of nifedipine was monitored by amperometry. Depolarization-triggered secretion in cells infected with either the wt α11.2 or α11.2/S1898A mutated subunit was elevated to a similar extent by forskolin. Forskolin, known to directly activate adenylyl-cyclase, increased the rate of secretion in a manner that is largely independent of the presence of S1898. Our results are consistent with the involvement of additional PKA regulatory site(s) at the C-tail of α11.2, the pore forming subunit of CaV1.2.
The voltage-gated calcium channels (VGCCs) are regulated by kinases that are activated by second messenger pathways [1–4]. The dihydropyridine-sensitive VGCC, known as the L-type channel or , is modulated by protein kinase A (PKA) and protein kinase C (PKC) . The β-adrenergic receptor activates cAMP-dependent phosphorylation by PKA, which increases the amplitude of voltage-dependent Ca2+ currents. It is now well established that the β-adrenergic signaling enhances inward Ca2+ currents via phosphorylation in cardiac myocytes [2, 4–6], adrenal chromaffin cells [7, 8], rat hippocampal neurons  and in skeletal muscle .
PKA phosphorylation of the L-type channel leads to an increase in the open probability () of the channel  and an increase in the mean open time by augmenting the number of long openings . In the heart activation of the β-adrenergic signaling pathways increases calcium currents ~4-fold and is attributed to the phosphorylation of .
The L-type channel assembles with Gs, adenylyl cyclase, PKA, and phosphatase PP2A into a signaling complex that enables the rapid modulation of the channel by the adrenergic receptor . Biochemical studies in the heart have shown that the distal C-terminal tail of the α11.2 subunit is phosphorylated by PKA on serine 1928 (S1928) [14–17]. Phosphorylation of S1928 in cardiac and neuronal cells implies β-adrenergic regulation of [4, 17–21].
The phosphorylation of S1928, the PKA consensus phosphorylation site at the α11.2 pore forming subunit of rabbit that is phosphorylated both in vitro and in vivo, was suggested to be responsible for the increase in Ca2+ currents .
Additional phosphorylation sites that can also participate in the β-adrenergic regulation of cardiac L-type Ca2+ channels  include the intracellular β-subunit of the channel [22, 23]. Since S1928 is phosphorylated also by PKC, it was suggested that both PKA and PKC signaling pathways converge at S1928 of the α11.2 subunit to increase channel activity .
More recently, the regulation of by the β-adrenergic pathway in mouse heart was tested in vivo using knock-in mouse with a targeted mutation of S1928 to alanine . This mutation, which abolished PKA phosphorylation of S1928, did not affect the kinetic characteristics and the β-adrenergic regulation of the L-type current. The conclusion led to the suggestion that PKA phosphorylation of S1928 in cardiomyocytes is functionally not involved in the β-adrenergic stimulation of -mediated calcium influx .
In neuroendocrine cells such as bovine chromaffin and PC12 cells, membrane depolarization triggers catecholamine (CA) secretion primarily by the opening of the L-type channels [26–28]. In these cells, the channel is an integral part of the signaling complex that triggers secretion [29–32]. Voltage-driven perturbations of a Ca2+-bound channel were suggested to transmit the signal from the channel to the exocytotic machinery and trigger fast release of vesicles assembled with the channel [28, 31, 33–35]. Therefore, channel phosphorylation would be expected to modify secretion. As previously shown, inhibitors of protein phosphorylation or injection of phosphatase 2A into cells suppresses facilitation of depolarization-evoked secretion . Based on these results it was suggested that facilitation is mediated by phosphorylation of voltage-dependent L-type Ca2+ channel .
We examined the modulation of L-type channel and its role in mediating evoked secretion using forskolin. Secretion was triggered in cells infected with the human wt α11.2 (Hu/wt) or α11.2/S1898A (Hu/S1898A) mutant subunit. The S1898 site corresponds to S1928 of rabbit cardiac cells. The frequency of the secretory events mediated by Hu/S1898A and Hu/wt-infected cells was accelerated by forskolin to a similar extent, indicating that mutating serine 1898 to alanine did not affect the forskolin-induced increase of catecholamine secretion.
Overall, our results suggest that additional PKA-sensitive phosphorylation sites contribute to the PKA modulation of catecholamine release.
2. Experimental Procedures
2.1. Materials and Methods
The complete human cDNAs of 1.2 subunit, accession number AJ224873, rabbit β2b accession number X64298, and rabbit α2/δ accession number NM_001082276, were kindly donated by Dr. M. Sanguinetti (University of Utah). A modified pSFV1 (Invitrogen) plasmid, where an internal ribosome entry site from poliovirus had been inserted followed by the gene for enhanced GFP, was provided by Dr. U. Ashery.
Standard methods of plasmid DNA preparation were used to prepare the human α11.2/S1989A. The α1 subunit coding sequence (AJ224873) was used as a template. The S1898A mutation was introduced by mutating the codon TCC to GCC by using the Bio-X-Act Long DNA Polymerase kit (Bioline, Israel) and Quick-change site-directed mutagenesis PCR was applied (Bioline, Israel). The following primers were used: 5′-TGCCTCACTAGGTCGAAGGGCCGCCTTCCACCTGGAATGTCTGAA and the 3′-TTCAGACATTCCAGGTGGAAGGCGGCCCTTCGACCTAGTGAGGCA. For amperometry studies, plasmids α11.2/T1036Y and α11.2/S1898/T1036Y were inserted upstream of the internal ribosome entry site using BamHI and BssHII restriction sites. All constructs were verified by DNA sequencing and restriction site mapping.
2.1.1. Chromaffin Cell Preparation and Culture
Bovine adrenal glands were obtained at a local slaughterhouse. The adrenal medulla cells were isolated as previously described in  and plated at a density of 5 × 104 cells/cm2 on glass cover slips placed in 35 mm plates, in DMEM (Gibco) supplemented with ITS-X (Sigma, Israel). Cells were incubated at 37°C in 5% CO2 and were used for amperometric recordings 1–4 days after preparation at 23°C.
2.1.2. Amperometric Recordings of Catecholamine Release from Chromaffin Cell
Amperometry recordings were carried out using 5 μm thin carbon fiber electrodes (CFE ALA Incorp. Westbury, NY, USA) and a VA-10 amplifier (NPI-electronic, Tamm, Germany) held at 800 mV as described previously . Cells were rinsed 4 times prior to the experiment and bathed during the recordings at 23°C in isoosmotic physiological solution (149 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM Glucose, and 10 mM HEPES, pH 7.3 at ~23°C (adjusted with NaOH)). Individual cells were stimulated to release by a 10 sec application of isoosmotic 60 mM KCl buffer from a ~3 μm tipped micropipette placed 5–7 μm from the cell in the bath. Amperometric currents were sampled at 10 kHz, using clampex 9.2 (Axon Instruments) and low-pass filter at 1 kHz.
Secretion of catecholamines from fluorescent cells identified at 480 nm excitation was recorded 16–24 hrs after infection by amperometry.
2.1.3. pSFV Infection
Virus Preparation and Infection
Recombinant SFV particles were generated as described previously in . Briefly, in vitro transcribed RNA from pSFV-GFP, or pSFV expressing GFP through an internal ribosome entry site (IRES) motif, pSFV-Nifedipine-insensitive α11.2-IRES-GFP, or pSFV-Nifedipine-insensitive α11.2/S1898A-IRES-GFP was coelectroporated into BHK-21 cells with pSFV-Helper-2 RNA. Virus stocks were harvested 24 hr later and activated with alpha-chymotrypsin before infection studies. Approximate titers were estimated by infection of known numbers of BHK-21 cells with serial dilutions of SFV stocks, and the GFP-positive cells were counted. Generally, titers in the range of 5 × 108 infectious particles/mL were obtained.
SFV particles (30 μL/dish) were added to the cultured cells (2 × 105 cells per dish) 5–48 h after plating. Infected cells were identified by their GFP fluorescence.
2.1.4. Amperometric Data Acquisition and Analysis
Rates of secretion were determined for individual cells and averaged. Spike frequencies were quantified for individual cells by the slopes of the cumulative events during 10 sec of KCl stimulation and a 20 sec poststimulus period (10–40 sec) and were averaged to obtain a cell mean. The rate of secretion during 10–40 sec was determined from the slopes of the corresponding cumulative spike plots. Data was analyzed as described in the text and figure legends. Error bars give standard errors. Spikes exceeding three times the background noise (>10 pA) were analyzed. All peaks identified by the program IGOR PRO (Wavemetrics, Lake Oswego, Or, USA) were inspected visually and bad signals were excluded manually.
2.1.5. Expression in Xenopus Oocytes and cRNA Injection
Stage V-VI Xenopus laevis oocytes were removed surgically from the ovaries of anesthetized animals and transferred to a Ca2+-free medium (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES, pH7.4) containing 1 mg/mL collagenase (253 U/mg) (Wortington Bioche. Corp. USA). The follicular cell layer was removed by shaking the oocytes in this buffer for 1.5–2 hr at room temperature. After extensive wash, the oocytes were transferred to ND96 buffer (96 mM NaCl, 3 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, and 5 mM HEPES, pH7.4) containing 2.5 mM pyruvate, 100 U/mL penicillin, and 10 μg/mL streptomycin. Oocytes were incubated in ND96 for 12–20 hr before cRNA injection.
2.1.6. cRNA Injection into Oocytes and Electrophysiology
cRNAs were prepared using the T7 Fermentas transcription kit (Lituania), and the product was monitored by gel electrophoresis and optical density measurements. In vitro transcribed capped cRNA of the channel subunits were injected into the defolliculated oocytes in a final volume of 40 nL using a Drummond 510 microinjector (Broomall, Pa, USA). Oocytes were maintained at 18°C for 5 days after injection .
2.1.7. Confocal Imaging
Single optical sections through the oocytes were obtained with an Olympus FV1000 (Olympus, Japan) equipped with a 40x oil objective (N.A. 1.3). Two excitation lasers were used sequentially: 488 nm GFP and narrow-band emission filters 505–525 nm. Sequential scanning was performed with a resolution set to 512 × 512 pixels (0.621 mm/pixel), and single optical sections ~0.5 μm thick were captured. Exposure time was 8 μsec/pixel.
3.1. Mutated Subunit Is Targeted to the Cell Membrane
The sequence homology of the phosphorylation consensus site of S1928 at the distal C-terminal of the α11.2 pore forming subunit corresponds to S1898 in the human α11.2, as shown in Figure 1(a). This highly conserved sequence in various species represents a PKA consensus phosphorylation motif (Figure 1(b)).
The consensus S1898 of the human α11.2 subunit was mutated to Ala and inserted into a frog expression vector. The cRNAs encoding the GFP-tagged human α11.2 subunit of or the GFP-α11.2/S1898A mutant were coinjected into oocytes along with the cRNAs encoding the auxiliary rabbit α2δ and β2b channel subunits (see Section 2). Oocytes imaged by confocal microscopy showed a similar mean gray value for both channels, indicating nearly identical level of protein expression and targeting to the membrane (Figure 1(c)).
3.2. Depolarization-Induced Secretion in Bovine Chromaffin Cells Is Largely Mediated by and Is Not Affected by the Viral Infection
Modulation of catecholamine secretion mediated by human α11.2 subunit was tested in bovine chromaffin cells.
At first, using a selective channel blocker, we confirmed that depolarization-evoked release is mediated primarily by the L-type channel (Figure 2(a)). The evoked release was significantly inhibited by 5 μm nifedipine present in the bath (Figure 2(a) inset). Averaged time courses of exocytosis in the absence and in the presence of 5 μM nifedipine are shown by the cumulative histograms (Figure 2(a), upper right). Spike frequencies were quantified for individual cells as initial rates, which correspond to the linear fits to the averaged cumulative histograms (bold lines) collected from cells () during the 10 sec of 60 mM KCl (K60) stimulation and a 20 sec poststimulus period (range 10–40 sec) (Figure 2(a), lower right).
We then tested the effect of Semliki Forest virus (SFV) infection on the rate of secretion in cells using SFV viral vector harboring GFP, as previously described . The infected fluorescent cells that were visualized using UV detection were depolarized by K60 for 10 sec and catecholamine release was monitored as amperometric spikes using carbon fiber electrode, where each spike represents the release of a single vesicle [36, 38]. Secretion from the fluorescent cells was monitored 16–24 hrs after infection. The extent of release was hardly affected by the infection procedure as seen in the amperometric traces (Figure 2(b)) consistent with previous studies [28, 37]. Evoked secretion was significantly decreased in the presence of nifedipine, in GFP-infected cells, similarly to noninfected cells (Figure 2(b) inset). The overall time course of secretion determined from the normalized waiting time distributions was 0.52 spike/sec in the GFP-infected cells (Figure 2(b), lower) and 0.53 spike/sec in noninfected cells (Figure 2(a), lower). No release was detected when the cells were stimulated in a Ca2+-free solution (Figure 2(c), left) or in the absence of K60 (Figure 2(c), right).
3.3. The Kinetic Parameters of Amperometric Spikes and Foot in Cells Infected with GFP- and the wt Human 1.2 (Hu/wt)
To study secretion mediated by the human channel, we created a pSFV vector expressing wt α11.2 human channel subunit (Hu/wt). As a control we monitored the kinetics of secretion induced in cells that were infected with pSFV vector expressing GFP (see above). Secretion mediated by the wt α11.2(Hu/wt) pSFV vector was monitored in the presence of 5 μM nifedipine. The nifedipine insensitivity was used to distinguish between the endogenous cellular channels and our cloned channels that were made resistant to nifedipine (Nif) by a single-amino-acid mutation, T1036Y . The T1036Y mutation rendered the channels completely impermeable to calcium ions as previously shown in HEK 293 cells and in Xenopus oocytes [28, 39]. Differences between the spike and pre-spikes (foot) kinetics elicited in GFP-infected and the Hu/wt-infected cells indicate differences between bovine and human . Representative amperometric spikes elicited by a 10 sec pulse of K60 from single GFP- and in Hu/wt-infected cells are shown in Figure 3(a). The kinetic parameters of amperometric currents, including peak amplitude, half-width, 50–90% rise time, and integrated spike (Q, gray area) as well as foot width, foot amplitude, and integrated foot (Q, white area), are presented schematically in Figure 3(b). The amperometric currents were quantified analyzing the distribution of the data depicted as cumulative probability in the GFP and the Hu/wt channel subunit (Figures 3(c)–3(f)). For every parameter, the values from each cell were averaged and presented as the mean of cell averages ± the standard error of the mean (SEM) for each group . The kinetic parameters of spikes including spike amplitude, 50–90% rise time, and mean-charge, were similar while the spike half-width was slightly higher in Hu/wt (Figures 3(e) and 3(f)).
The foot amplitude and the kinetics of foot width were not significantly different, calculated by analyzing the distribution of the data and depicted as cumulative probability in the GFP- and the Hu/wt-infected cells (Figures 3(g) and 3(h)).
3.4. The Kinetic Parameters of Amperometric Spike and Foot Elicited by Human wt and Mutated S1898A Channels
The α11.2 (Hu/wt) or the α11.2/S1898A (Hu/S18989A) subunits that harbored a second mutation T1036Y that rendered the channel nifedipine insensitive were subcloned into a pSFV, which expresses GFP through an internal ribosome entry site (IRES) motif . Both Hu/wt and the mutated Hu/S1898A subunits, which included GFP, were made dihydropyridine insensitive and enabled discrimination of secretion mediated by exogenously expressed human channels from that of native bovine calcium channels [28, 39]. We tested the kinetic parameters of cells infected with either Hu/wt or Hu/S1898A subunits in the presence of 5 μM nifedipine, 16–24 hrs after infection as shown by representative amperometric currents (Figures 4(a) and 4(b)). The amperometric spikes elicited in the Hu/wt, and Hu/S1898A-infected cells were quantified by analyzing the distribution of the data, depicted as cumulative probability (Figures 4(c)–4(f); see also Figure 3). For every parameter, the values from each cell were averaged and presented as the mean of cell averages ± the standard error of the mean (SEM) for each group . The mutation of Ser 1898 to Ala, which prevents the phosphorylation at this site, enabled the examination of the net effect of this site on the kinetics of spike and foot parameters. The mutation did not affect spike and foot kinetics as shown by the mean distribution of peak amplitude, half-width, charge, or 50−90% rise-time (Figures 4(c)–4(f)).
In addition, foot values that correspond to the pre-spike signal and depict the properties of the fusion pore  did not show any significant changes in the mean distribution of the cumulative events (Figures 4(g) and 4(h)).
3.5. Forskolin Increases the Rate of Secretion
To gain insight into the specific contribution of the corresponding consensus PKA site S1898 to the regulation of catecholamine release mediated via , we applied forskolin to cells infected with Hu/wt and Hu/S1898A.
The effect of forskolin on secretion was tested at first, on GFP-infected cells. As shown by the amperometric currents (Figure 5(a)), 1 μM forskolin when applied to GFP-infected cells increased the frequency of the amperometric events. The analysis of cumulative spikes showed an increase from 21 ± 3 to 33 ± 3.1 spikes/cell (Table 1) and a 1.5-fold increase in the initial rate from 0.52 ± 0.01 to 0.79 ± 0.03 spike/sec (Figure 5(c) left). The increase in the frequency of the amperometric events induced by forskolin also led to a 1.6-fold increase in total catecholamine secretion, which was calculated as the total mean charge of spike area within the range of 10–40 sec during and after stimulation (Figure 5(c) right; Table 1).
|Cells were stimulated for 10 sec by 60 mM KCl. Amperometric currents were measured during time range of 10–40 sec, which includes the 10 sec K60 stimulation and a 20 sec poststimulus period.|
a1 μM forskolin (FSK);*.
Next, we compared the effect of forskolin on secretion mediated by the Hu/wt or Hu/S1898A. Shown by representative amperometric traces, forskolin accelerated the rate of secretion in cells infected with either Hu/wt or Hu/S1898A (Figure 6(a)). The increase in the frequency of the amperometric spikes induced by forskolin was quantified as described above (see Figure 2). In both the GFP- and Hu/wt-infected cells, the rate of secretion was increased 1.5-fold, and in the Hu/S1898A-infected cells 1.3-fold (Figures 6(a) and 6(b) and Table 1). Forskolin increased the total release of catecholamine to a similar extent (1.6-fold), in the GFP-, Hu/wt-, or Hu/S1898A-infected cells, as summarized in the bar graph (Figure 6(c)) and Table 1.
Forskolin induced a similar upregulation of release events mediated by the human Hu/wt and the endogenous bovine channel (measured in cells infected with GFP). A smaller increase (1.3-fold compared to 1.5-fold) was observed in Hu/S1898A-infected cells.
3.6. The Effects of Forskolin on the Kinetics of the Amperometric Spikes and Foot
In spite of the increase in the frequency of secretion by forskolin, no effect on the kinetics of the individual amperometric spikes and prespikes (foot) was observed, as presented in Table SI of the supplementary material available online at http://dx.doi.org/10.1155/2011/746482.
4.1. The Contribution of S1898 to the Rate of Secretion in Chromaffin Cells
In bovine chromaffin cells membrane depolarization triggers catecholamine release primarily via the activation of the dihydropyridine-sensitive VGCC, known as the L-type channel. This was previously shown using selective DHP L-type channel blockers [26, 28]. The activity of like other VGCC is further modulated by phosphorylation [2, 4].
Phosphorylation of the L-type channel or by protein Kinase A (PKA) and protein kinase C (PKC) further modulates the kinetics of the channel . Biochemical studies in the heart and in neuronal cells have shown that the distal C-terminal tail of the α11.2 subunit is phosphorylated by PKA on serine 1928 (S1928) [14–17]. This consensus phosphorylation site corresponds to S1898 in the human , and here we have tested whether this site at the human pore forming α11.2 subunit contributes to the regulation of catecholamine release in bovine chromaffin cells.
At first we confirmed that bovine chromaffin cells infected with pSFV vector containing GFP retained their sensitivity to nifedipine. Secretion of CA that was monitored using carbon fiber amperometry was reduced by more than 85%.
Both the human wt α11.2 (Hu/wt) and the α11.2/S1898A (Hu/S1898A) subunits, which are equally expressed and targeted to the cell membrane, were introduced into chromaffin cells via Semliki forest viral infection. The two channel subunits each harbored an additional mutation that rendered them nifedipine insensitive. Secretion in the infected cells was carried out in the presence of nifedipine, which enabled the functional discrimination of L-type-mediated secretion contributed by exogenously expressed human channels from that of native bovine Ca2+ channels. The frequency of secretion and the total catecholamine released that was mediated by the endogenous bovine channel was similar to that of the human α11.2 (Hu/wt) channel. Also the spike parameters and the prespike (foot) parameters were indistinguishable.
4.2. Forskolin Elevated Depolarization-Evoked Secretion Independently of S1898
Protein microsequencing of phospho-peptide mapping confirmed that phosphorylation occurs at a PKA site, at serine 1928 near the C-terminus of cardiac α11.2 . Based on these results it was suggested that the single PKA consensus site S1928 is involved in the β-adrenergic receptor modulation of channel activity.
Forskolin is known to activate adenylyl cyclase, which by producing cAMP and activating PKA, leads to the phosphorylation of the α1 subunits of the L-type channel thereby, upregulating its activity. It was previously shown that forskolin elevation of cAMP could be fully accounted for by the activation of the β-adrenergic receptor [25, 42, 43]. Using forskolin, we tested the contribution of the human α11.2 subunit to secretion by mutating Ser1898 to Ala, the site that corresponds to the S1928 in rabbit cardiac α11.2 subunit.
The modulation of secretion by the PKA activation pathway was tested by forskolin that was applied to chromaffin cells infected with the Hu/wt or Hu/S1898A subunits.
The direct activation of adenylyl-cyclase by forskolin in GFP-infected and in the Hu/wt-infected cells led to a similar fold increase in the rate of depolarization-evoked secretion and total catecholamine release. These results suggest that the human α1 subunit was most likely phosphorylated by PKA to the same extent as the endogenous α1 subunit.
On the other hand, the positive impact of forskolin on the rate of secretion was slightly lower in cells infected with the Hu/S1898A subunit. These results suggest that forskolin upregulates evoked secretion only marginally via S1898.
These results are in agreement with others  who have demonstrated that the phosphorylation of S1928 in the rabbit channel accounts only partially (~20–30%) for the β-adrenergic regulation of calcium currents in cardiomyocytes . Furthermore, in mice, no detectable differences in heart rate were detected compared to control animals during isoproterenol infusion . It is predicted that forskolin mediates phosphorylation through additional site(s) either at the α11.2 subunit or in other channel subunits [22, 44] and only marginally through S1898. Previous studies have also shown that phosphorylation of this site involves PKC .
In our studies, both the Hu/wt and the Hu/S1898A channel subunits mediate faster rate of secretion by forskolin. Since forskolin modified secretion largely independently of the presence of Ser or Ala at position 1898, we concluded that the cAMP-dependent PKA has contributed to the modulation of secretion via other selective sites . Other studies have proposed that the cardiac L-type Ca2+ channels are phosphorylated in basal state by high levels of PKA phosphorylation, while dephosphorylation reduces their activity [19, 45].
In summary, our results show that mutating S1898 hardly affected the forskolin-induced increase in depolarization-evoked secretion in the neuroendocrine cells. Given that a similar forskolin-mediated increase in the rate of secretion was observed in cells infected with Hu/wt and Hu/S1898A mutant, our results indicate that other phosphorylation sites either at the L-type channel auxiliary subunits or other proteins of the secretory apparatus are involved in the upregulation of depolarization-evoked secretion in chromaffin cells.
The authors thank Michael Trus for commenting and editing the paper and Khaled Zoabe for providing the adrenal glands. This paper is supported by the Betty Feffer foundation for D.A.
Supporting material: The kinetic parameters of the spikes and foot of elicited in bovine chromaffin cells infected by pSFV vectors of the α111.2 subunits of Hu/wt and Hu/S1898A. The cells were stimulated by a 10 sec puff of 60mM KCl (see Experimental Procedures).
- H. Reuter, “Calcium channel modulation by β-adrenergic neurotransmitters in the heart,” Experientia, vol. 43, no. 11-12, pp. 1173–1175, 1987.
- A. C. Dolphin, “L-type calcium channel modulation,” Advances in Second Messenger and Phosphoprotein Research, vol. 33, pp. 153–177, 1999.
- K. Nunoki, V. Florio, and W. A. Catterall, “Activation of purified calcium channels by stoichiometric protein phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 17, pp. 6816–6820, 1989.
- W. A. Catterall, “Structure and regulation of voltage-gated Ca2+ channels,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 521–555, 2000.
- B. P. Bean, M. C. Nowycky, and R. W. Tsien, “β-Adrenergic modulation of calcium channels in frog ventricular heart cells,” Nature, vol. 307, no. 5949, pp. 371–375, 1984.
- T. F. Mcdonald, S. Pelzer, W. Trautwein, and D. J. Pelzer, “Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells,” Physiological Reviews, vol. 74, no. 2, pp. 365–507, 1994.
- C. A. Artalejo, M. K. Dahmer, R. L. Perlman, and A. P. Fox, “Two types of Ca2+ currents are found in bovine chromaffin cells: facilitation is due to the recruitment of one type,” Journal of Physiology, vol. 432, pp. 681–707, 1991.
- C. R. Artalejo, S. Rossie, R. L. Perlman, and A. P. Fox, “Voltage-dependent phosphorylation may recruit Ca2+ current facilitation in chromaffin cells,” Nature, vol. 358, no. 6381, pp. 63–66, 1992.
- E. T. Kavalali, K. S. Hwang, and M. R. Plummer, “cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons,” Journal of Neuroscience, vol. 17, no. 14, pp. 5334–5348, 1997.
- A. Sculptoreanu, E. Rotman, M. Takahashi, T. Scheuer, and W. A. Catterall, “Voltage-dependent potentiation of the activity of cardiac L-type calcium channel α1 subunits due to phosphorylation by cAMP-dependent protein kinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 21, pp. 10135–10139, 1993.
- D. T. Yue, S. Herzig, and E. Marban, “β-Adrenergic stimulation of calcium channels occurs by potentiation of high-activity gating modes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 2, pp. 753–757, 1990.
- D. M. Bers, “Cardiac excitation-contraction coupling,” Nature, vol. 415, no. 6868, pp. 198–205, 2002.
- M. A. Davare, V. Avdonin, D. D. Hall et al., “A β2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav 1.2,” Science, vol. 293, no. 5527, pp. 98–101, 2001.
- K. S. De Jongh, B. J. Murphy, A. A. Colvin, J. W. Hell, M. Takahashi, and W. A. Catterall, “Specific phosphorylation of a site in the full-length form of the α1 subunit of the cardiac L-type calcium channel by adenosine --cyclic monophosphate-dependent protein kinase,” Biochemistry, vol. 35, no. 32, pp. 10392–10402, 1996.
- J. Mitterdorfer, M. Froschmayr, M. Grabner, F. F. Moebius, H. Glossmann, and J. Striessnig, “Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel α1 subunits,” Biochemistry, vol. 35, no. 29, pp. 9400–9406, 1996.
- P. C. Gray, J. D. Scott, and W. A. Catterall, “Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins,” Current Opinion in Neurobiology, vol. 8, no. 3, pp. 330–334, 1998.
- J. T. Hulme, R. E. Westenforoek, T. Scheuer, and W. A. Catterall, “Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac Cav1.2 channels during β1-adrenergic regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 44, pp. 16574–16579, 2006.
- J. W. Hell, C. T. Yokoyama, S. T. Wong, C. Warner, T. P. Snutch, and W. A. Catterall, “Differential phosphorylation of two size forms of the neuronal class C L- type calcium channel α1 subunit,” The Journal of Biological Chemistry, vol. 268, no. 26, pp. 19451–19457, 1993.
- T. Perets, Y. Blumenstein, E. Shistik, I. Lotan, and N. Dascal, “A potential site of functional modulation by protein kinase A in the cardiac Ca2+ channel α1c subunit,” FEBS Letters, vol. 384, no. 2, pp. 189–192, 1996.
- M. A. Davare and J. W. Hell, “Increased phosphorylation of the neuronal L-type Ca2+ channel Cav1.2 during aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 16018–16023, 2003.
- D. D. Hall, J. A. Feekes, A. S. Arachchige Don et al., “Binding of protein phosphatase 2A to the L-type calcium channel Ca v1.2 next to Ser1928, its main PKA site, is critical for Ser1928 dephosphorylation,” Biochemistry, vol. 45, no. 10, pp. 3448–3459, 2006.
- M. Bünemann, B. L. Gerhardstein, T. Gao, and M. M. Hosey, “Functional regulation of L-type calcium channels via protein kinase A- mediated phosphorylation of the β2 subunit,” The Journal of Biological Chemistry, vol. 274, no. 48, pp. 33851–33854, 1999.
- A. N. Ganesan, C. Maack, D. C. Johns, A. Sidor, and B. O'Rourke, “β-Adrenergic stimulation of L-type Ca2+ channels in cardiac myocytes requires the distal carboxyl terminus of α1C but not serine 1928,” Circulation Research, vol. 98, no. 2, pp. e11–e18, 2006.
- L. Yang, G. Liu, S. I. Zakharov et al., “Ser1928 is a common site for Cav1.2 phosphorylation by protein kinase C isoforms,” The Journal of Biological Chemistry, vol. 280, no. 1, pp. 207–214, 2005.
- T. Lemke, A. Welling, C. J. Christel et al., “Unchanged β-adrenergic stimulation of cardiac L-type calcium channels in Cav1.2 phosphorylation site S1928A mutant mice,” The Journal of Biological Chemistry, vol. 283, no. 50, pp. 34738–34744, 2008.
- V. Cena, G. P. Nicolas, P. Sanchez Garcia, S. M. Kirpekar, and A. G. Garcia, “Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release,” Neuroscience, vol. 10, no. 4, pp. 1455–1462, 1983.
- B. Avidor, T. Avidor, L. Schwartz, K. S. De Jongh, and D. Atlas, “Cardiac L-type Ca2+ channel triggers transmitter release in PC12 cells,” FEBS Letters, vol. 342, no. 2, pp. 209–213, 1994.
- Y. Hagalili, N. Bachnoff, and D. Atlas, “The Voltage-gated Ca2+ channel is the Ca2+ sensor protein of secretion,” Biochemistry, vol. 47, no. 52, pp. 13822–13830, 2008.
- O. Wiser, M. K. Bennett, and D. Atlas, “Functional interaction of syntaxin and SNAP-25 with voltage-sensitive L- and N-type Ca2+ channels,” EMBO Journal, vol. 15, no. 16, pp. 4100–4110, 1996.
- O. Wiser, M. Trus, A. Hernández et al., “The voltage sensitive Lc-type Ca2+ channel is functionally coupled to the exocytotic machinery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 1, pp. 248–253, 1999.
- M. Trus, R. F. Corkey, R. Nesher et al., “The L-type voltage-gated Ca2+ channel is the Ca2+ sensor protein of stimulus-secretion coupling in pancreatic beta cells,” Biochemistry, vol. 46, no. 50, pp. 14461–14467, 2007.
- D. Atlas, “Functional and physical coupling of voltage-sensitive calcium channels with exocytotic proteins: ramifications for the secretion mechanism,” Journal of Neurochemistry, vol. 77, no. 4, pp. 972–985, 2001.
- R. Cohen, B. M. Schmitt, and D. Atlas, “Molecular identification and reconstitution of depolarization-induced exocytosis monitored by membrane capacitance,” Biophysical Journal, vol. 89, no. 6, pp. 4364–4373, 2005.
- I. Lerner, M. Trus, R. Cohen, O. Yizhar, I. Nussinovitch, and D. Atlas, “Ion interaction at the pore of Lc-type Ca2+ channel is sufficient to mediate depolarization-induced exocytosis,” Journal of Neurochemistry, vol. 97, no. 1, pp. 116–127, 2006.
- R. Cohen, B. M. Schmitt, and D. Atlas, “Reconstitution of depolarization and Ca2+-evoked secretion in xenopus oocytes monitored by membrane capacitance,” Methods in Molecular Biology, vol. 440, pp. 269–282, 2008.
- R. H. Chow, L. Von Ruden, and E. Neher, “Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells,” Nature, vol. 356, no. 6364, pp. 60–63, 1992.
- U. Ashery, A. Betz, X. Tao, N. Brose, and J. Rettig, “An efficient method for infection of adrenal chromaffin cells using the Semliki Forest virus gene expression system,” European Journal of Cell Biology, vol. 78, no. 8, pp. 525–532, 1999.
- R. M. Wightman, J. A. Jankowski, R. T. Kennedy et al., “Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 23, pp. 10754–10758, 1991.
- M. He, I. Bodi, G. Mikala, and A. Schwartz, “Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study,” The Journal of Biological Chemistry, vol. 272, no. 5, pp. 2629–2633, 1997.
- T. L. Colliver, E. J. Hess, E. N. Pothos, D. Sulzer, and A. G. Ewing, “Quantitative and statistical analysis of the shape of amperometric spikes recorded from two populations of cells,” Journal of Neurochemistry, vol. 74, no. 3, pp. 1086–1097, 2000.
- C. T. Wang, R. Grishanin, C. A. Earles et al., “Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles,” Science, vol. 294, no. 5544, pp. 1111–1115, 2001.
- A. Yatani, J. Codina, Y. Imoto, J. Reeves, L. Birnbaumer, and A. M. Brown, “A G protein directly regulates mammalian cardiac calcium channels,” Science, vol. 238, no. 4831, pp. 1288–1292, 1987.
- H. C. Hartzell, P. F. Mery, R. Fischmeister, and G. Szabo, “Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation,” Nature, vol. 351, no. 6327, pp. 573–576, 1991.
- H. Haase, J. Alvarez, D. Petzhold et al., “Ahnak is critical for cardiac Ca(v)1.2 calcium channel function and its β-adrenergic regulation,” FASEB Journal, vol. 19, no. 14, pp. 1969–1977, 2005.
- D. Singer-Lahat, I. Lotan, M. Biel, V. Flockerzi, F. Hofmann, and N. Dascal, “Cardiac calcium channels expressed in xenopus oocytes are modulated by dephosphorylation but not by cAMP-Dependent phosphorylation,” Receptors and Channels, vol. 2, no. 3, pp. 215–226, 1994.
Copyright © 2011 Niv Bachnoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.